Total Funding
57
46
Total FundingPost-IPO Equity raised
Growth Score
-14 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
151134
Modalis is a biotech company that develops therapeutics using CRISPR based technology.
Haru Morita: Co-Founder, President, and CEOPast Role: REGiMMUNE, President, Chief Executive Officer and Director
About the Company
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
